NVDA Add to watchlist
$198.87 +2.36 (+1.20%)
After Hours: $198.87 +0.00 (+0.00%)
Last updated: Apr 15, 2026 23:08
52-Week Range
$198.87
$95.04 $198.87 $212.19

Fundamentals Overview

NVIDIA Corporation is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 40.5 PEG 0.63 P/B 30.73 P/S 22.38

Intrinsic value (DCF)

+20.4% upside vs price

Profitability

Net margin 55.6%

Risk (Beta)

2.34 — higher vol

Earnings & growth

EPS $4.91 Rev +19.5% Profit +34.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 65% confidence Risk: High Volatility — Beta 2.34. Consider smaller position size due to higher beta.

Supporting (Buy):

DCF +20.4% upside vs price · Analyst grade: A- · 3M vs S&P 500: +6.8% · 3M vs Technology sector: +5.1%

Pressures (Sell):

Beta 2.34 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$4,833.54B
P/E (TTM)
40.47
EPS (TTM)
$4.91
Dividend Yield
0.01%
52-Week Range
$95.04 - $212.19
Volume vs Avg
N/A
Beta
2.34

About

NVIDIA Corporation provides graphics, and compute and networking solutions in the United States, Taiwan, China, and internationally. The company's Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for...
Sector: Technology
Headquarters: US
Employees: 36,000
IPO Date: Jan 1999
Beta: 2.34 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Current institutional positions: Buy: 16, Outperform: 5, Overweight: 7, Strong Buy: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $239.49; current price is $198.87. That’s a +20.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 40.47
DCF value (model) $239.49 (20.4% upside)
PEG (TTM) 0.63
P/B (TTM) 30.73
P/S (TTM) 22.38
P/FCF (TTM) 50
Liquidity & enterprise
Current Ratio (TTM) 3.91
Quick Ratio (TTM) 3.24
Cash Ratio (TTM) 0.33
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 55.6%
Gross margin (TTM) 71.07%
Operating margin (TTM) 60.38%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for NVDA.

Analyst Sentiment at a Glance

A-
Buy 16Outperform 5Overweight 7Strong Buy 2
Price Target Consensus
Current $198.87
Median $275.00
Consensus $277.82
Low consensus $140.00
High consensus $400.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Benchmark maintain Buy Buy 2026-03-31
Rosenblatt maintain Buy Buy 2026-03-23
Cantor Fitzgerald maintain Overweight Overweight 2026-03-23
Raymond James maintain Strong Buy Strong Buy 2026-03-19
Rosenblatt maintain Buy Buy 2026-03-18
Needham maintain Buy Buy 2026-03-18
Truist Securities maintain Buy Buy 2026-03-18
TD Cowen maintain Buy Buy 2026-03-17
Benchmark maintain Buy Buy 2026-03-17
Rosenblatt maintain Buy Buy 2026-03-17
RBC Capital maintain Outperform Outperform 2026-03-17
Keybanc maintain Overweight Overweight 2026-03-17
Cantor Fitzgerald maintain Overweight Overweight 2026-03-17
Cantor Fitzgerald maintain Overweight Overweight 2026-03-12
Tigress Financial maintain Strong Buy Strong Buy 2026-03-05
Wedbush maintain Outperform Outperform 2026-03-03
Needham maintain Buy Buy 2026-02-26
Oppenheimer maintain Outperform Outperform 2026-02-26
Morgan Stanley maintain Overweight Overweight 2026-02-26
B of A Securities maintain Buy Buy 2026-02-26
Bernstein maintain Outperform Outperform 2026-02-26
Rosenblatt maintain Buy Buy 2026-02-26
Truist Securities maintain Buy Buy 2026-02-26
JP Morgan maintain Overweight Overweight 2026-02-26
Wedbush maintain Outperform Outperform 2026-02-26
Keybanc maintain Overweight Overweight 2026-02-26
Citigroup maintain Buy Buy 2026-02-26
DA Davidson maintain Buy Buy 2026-02-26
Benchmark maintain Buy Buy 2026-02-26
TD Cowen maintain Buy Buy 2026-02-26